SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Kristina Bliznakova, Nikola Kolev, Ivan Buliev, Anton Tonev, Elitsa Encheva, Zhivko Bliznakov, Krasimir Ivanov, Computer Aided Preoperative Evaluation of the Residual Liver Volume Using Computed Tomography Images, Journal of Digital Imaging, 2015, 28, 2, 231

    CrossRef

  2. 2
    Teodor Kapitanov, Ulf P. Neumann, Maximilian Schmeding, Hepatocellular Carcinoma in Liver Cirrhosis: Surgical Resection versus Transarterial Chemoembolization—A Meta-Analysis, Gastroenterology Research and Practice, 2015, 2015, 1

    CrossRef

  3. 3
    W. Sohn, Y.-H. Paik, J. Y. Cho, J. Ma Ahn, G. S. Choi, J. M. Kim, C. H. Kwon, J. W. Joh, D. H. Sinn, G.-Y. Gwak, M. S. Choi, J. H. Lee, K. C. Koh, S. W. Paik, B. C. Yoo, Influence of hepatitis B virus reactivation on the recurrence of HBV-related hepatocellular carcinoma after curative resection in patients with low viral load, Journal of Viral Hepatitis, 2015, 22, 6
  4. 4
    Anne M. Walling, Hannah Schreibeis-Baum, Neville Pimstone, Steven M. Asch, Linda Robinson, Sheri Korlekar, Karl Lorenz, Tracy Nwajuaku, Kenneth Rosenfeld, Proactive Case Finding To Improve Concurrently Curative and Palliative Care in Patients with End-Stage Liver Disease, Journal of Palliative Medicine, 2015, 18, 4, 378

    CrossRef

  5. 5
    Yukio Tokumitsu, Takao Tamesa, Satoshi Matsukuma, Noriaki Hashimoto, Yoshinari Maeda, Yoshihiro Tokuhisa, Kazuhiko Sakamoto, Tomio Ueno, Shoichi Hazama, Hiroyuki Ogihara, Yusuke Fujita, Yoshihiko Hamamoto, Masaaki Oka, Norio Iizuka, An accurate prognostic staging system for hepatocellular carcinoma patients after curative hepatectomy, International Journal of Oncology, 2014,

    CrossRef

  6. 6
    Jin-Young Choi, Jeong-Min Lee, Claude B. Sirlin, CT and MR Imaging Diagnosis and Staging of Hepatocellular Carcinoma: Part II. Extracellular Agents, Hepatobiliary Agents, and Ancillary Imaging Features, Radiology, 2014, 273, 1, 30

    CrossRef

  7. 7
    R. Lencioni, M. Kudo, S.-L. Ye, J.-P. Bronowicki, X.-P. Chen, L. Dagher, J. Furuse, J. F. Geschwind, L. Ladrón Guevara, C. Papandreou, T. Takayama, S. K. Yoon, K. Nakajima, R. Lehr, S. Heldner, A. J. Sanyal, GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis, International Journal of Clinical Practice, 2014, 68, 5
  8. 8
    Won Sohn, Yong-Han Paik, Jong Man Kim, Choon Hyuk Kwon, Jae Won Joh, Ju Yeon Cho, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo, HBV DNA and HBsAg Levels as Risk Predictors of Early and Late Recurrence after Curative Resection of HBV-related Hepatocellular Carcinoma, Annals of Surgical Oncology, 2014, 21, 7, 2429

    CrossRef

  9. 9
    Sudhakar K. Venkatesh, Vishal Chandan, Lewis R. Roberts, Liver Masses: A Clinical, Radiologic, and Pathologic Perspective, Clinical Gastroenterology and Hepatology, 2014, 12, 9, 1414

    CrossRef

  10. 10
    Dirk Graf, Daniel Vallböhmer, Wolfram Trudo Knoefel, Patric Kröpil, Gerald Antoch, Abdurrahaman Sagir, Dieter Häussinger, Multimodal treatment of hepatocellular carcinoma, European Journal of Internal Medicine, 2014, 25, 5, 430

    CrossRef

  11. 11
    Brian K. P. Goh, Pierce K. H. Chow, Jin-Yao Teo, Jen-San Wong, Chung-Yip Chan, Peng-Chung Cheow, Alexander Y. F. Chung, London L. P. J. Ooi, Number of Nodules, Child-Pugh Status, Margin Positivity, and Microvascular Invasion, but not Tumor Size, are Prognostic Factors of Survival after Liver Resection for Multifocal Hepatocellular Carcinoma, Journal of Gastrointestinal Surgery, 2014, 18, 8, 1477

    CrossRef

  12. 12
    Won Sohn, Yong-Han Paik, Min Woo Lee, Hyunchul Rhim, Hyo Keun Lim, Ju Yeon Cho, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo, Predisposing factors for recurrence of HBV-related small hepatocellular carcinoma after percutaneous radiofrequency ablation, Scandinavian Journal of Gastroenterology, 2014, 49, 3, 373

    CrossRef

  13. 13
    G. Martinez-Mier, S. Esquivel-Torres, J.P. Medina Granados, M. Luna-Castillo, R. Castillo-Chiquete, J.F. Calzada-Grijalva, F. Gonzalez-Velazquez, Presentación, clasificación y evolución de los pacientes con carcinoma hepatocelular en un centro de Veracruz, México, Revista de Gastroenterología de México, 2014, 79, 3, 171

    CrossRef

  14. 14
    G. Martinez-Mier, S. Esquivel-Torres, J.P. Medina Granados, M. Luna-Castillo, R. Castillo-Chiquete, J.F. Calzada-Grijalva, F. Gonzalez-Velazquez, Presentation, staging, and outcome of patients with hepatocellular carcinoma at a center in Veracruz, Mexico, Revista de Gastroenterología de México (English Edition), 2014, 79, 3, 171

    CrossRef

  15. 15
    Won Sohn, Yong-Han Paik, Ju-Yeon Cho, Ho Yeong Lim, Jem Ma Ahn, Dong Hyun Sinn, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo, Sorafenib therapy for hepatocellular carcinoma with extrahepatic spread: Treatment outcome and prognostic factors, Journal of Hepatology, 2014,

    CrossRef

  16. 16
    Silvana C. Faria, Janio Szklaruk, Ahmed O. Kaseb, Hesham M. Hassabo, Khaled M. Elsayes, TNM/Okuda/Barcelona/UNOS/CLIP International Multidisciplinary Classification of Hepatocellular Carcinoma: concepts, perspectives, and radiologic implications, Abdominal Imaging, 2014, 39, 5, 1070

    CrossRef

  17. 17
    Rüdiger Hoffmann, Hansjörg Rempp, Roland Syha, Dominik Ketelsen, Philippe L. Pereira, Claus D. Claussen, Stephan Clasen, Transarterial chemoembolization using drug eluting beads and subsequent percutaneous MR-guided radiofrequency ablation in the therapy of intermediate sized hepatocellular carcinoma, European Journal of Radiology, 2014, 83, 10, 1793

    CrossRef

  18. 18
    J.-s. Zheng, J. Long, B. Sun, N.-n. Lu, D. Fang, L.-y. Zhao, N. Du, Transcatheter arterial chemoembolization combined with radiofrequency ablation can improve survival of patients with hepatocellular carcinoma with portal vein tumour thrombosis: Extending the indication for ablation?, Clinical Radiology, 2014, 69, 6, e253

    CrossRef

  19. 19
    Bo Hyun Kim, Joong-Won Park, Byung-Ho Nam, Hee Won Kwak, W. Ray Kim, Validation of a model to estimate survival in ambulatory patients with hepatocellular carcinoma: a single-centre cohort study, Liver International, 2014, 34, 7
  20. 20
    Kwong-Fai Wong, Zhi Xu, Jinfei Chen, Nikki P Lee, John M Luk, Circulating markers for prognosis of hepatocellular carcinoma, Expert Opinion on Medical Diagnostics, 2013, 7, 4, 319

    CrossRef

  21. 21
    Lu-En Wai, Vipin Narang, Alexandre Gouaillard, Lai Guan Ng, Jean-Pierre Abastado, In silico modeling of cancer cell dissemination and metastasis, Annals of the New York Academy of Sciences, 2013, 1284, 1
  22. 22
    A Aigelsreiter, A L Ress, K Bettermann, S Schauer, K Koller, F Eisner, T Kiesslich, T Stojakovic, H Samonigg, P Kornprat, C Lackner, J Haybaeck, M Pichler, Low expression of the putative tumour suppressor spinophilin is associated with higher proliferative activity and poor prognosis in patients with hepatocellular carcinoma, British Journal of Cancer, 2013, 108, 9, 1830

    CrossRef

  23. 23
    P. T. W. Kim, J.-H. Jang, E. G. Atenafu, S. Fischer, P. D. Greig, I. D. McGilvray, A. C. Wei, S. Gallinger, S. P. Cleary, Outcomes after hepatic resection and subsequent multimodal treatment of recurrence for multifocal hepatocellular carcinoma, British Journal of Surgery, 2013, 100, 11
  24. 24
    Fasika B. Aberra, Mary Essenmacher, Natalie Fisher, Michael L. Volk, Quality Improvement Measures Lead to Higher Surveillance Rates for Hepatocellular Carcinoma in Patients with Cirrhosis, Digestive Diseases and Sciences, 2013, 58, 4, 1157

    CrossRef

  25. 25
    Wei Qi, Weicheng Liang, Huiqing Jiang, Mary Miuyee Waye, The Function of miRNA in Hepatic Cancer Stem Cell, BioMed Research International, 2013, 2013, 1

    CrossRef

  26. 26
    Karim M. Eltawil, Robert Berry, Mohamed Abdolell, Michele Molinari, Analysis of survival predictors in a prospective cohort of patients undergoing transarterial chemoembolization for hepatocellular carcinoma in a single Canadian centre, HPB, 2012, 14, 3
  27. 27
    Yasuaki Arai, Clinical trials of interventional oncology, International Journal of Clinical Oncology, 2012, 17, 4, 301

    CrossRef

  28. 28
    Sene Waly Raphael, Zhang Yangde, Chen YuXiang, Hepatocellular Carcinoma: Focus on Different Aspects of Management, ISRN Oncology, 2012, 2012, 1

    CrossRef

  29. 29
    Bu-Yeo Kim, Kyung-Suk Suh, Je-Geun Lee, Seon Rang Woo, In-Chul Park, Sun-Hoo Park, Chul Ju Han, Sang-Bum Kim, Sook-Hyang Jeong, Young Il Yeom, Suk-Jin Yang, Chang-Min Kim, Su Jin Cho, Young Do Yoo, Myung-Haing Cho, Ja June Jang, Dong Wook Choi, Kee-Ho Lee, Integrated Analysis of Prognostic Gene Expression Profiles from Hepatitis B Virus-Positive Hepatocellular Carcinoma and Adjacent Liver Tissue, Annals of Surgical Oncology, 2012, 19, S3, 328

    CrossRef

  30. 30
    Stephen L. CHAN, Philip JOHNSON, Intra-arterial infusion of chemotherapy for advanced hepatocellular carcinoma: An Asian perspective, Asia-Pacific Journal of Clinical Oncology, 2012, 8, 2
  31. 31
    Stephen L. Chan, Tony Mok, Brigette B. Y. Ma, Management of Hepatocellular Carcinoma: Beyond Sorafenib, Current Oncology Reports, 2012, 14, 3, 257

    CrossRef

  32. 32
    Jennifer Guy, Robin K. Kelley, John Roberts, Robert Kerlan, Francis Yao, Norah Terrault, Multidisciplinary Management of Hepatocellular Carcinoma, Clinical Gastroenterology and Hepatology, 2012, 10, 4, 354

    CrossRef

  33. 33
    José A. Agúndez, Elena García-Martín, María J. Devesa, Miguel Carballo, Carmen Martínez, Anna Lee-Brunner, Cristina Fernández, Manuel Díaz-Rubio, José M. Ladero, Polymorphism of the TLR4 Gene Reduces the Risk of Hepatitis C Virus-Induced Hepatocellular Carcinoma, Oncology, 2012, 82, 1, 35

    CrossRef

  34. 34
    Karim M. Eltawil, Robert Berry, Mohamed Abdolell, Michele Molinari, Quality of life and survival analysis of patients undergoing transarterial chemoembolization for primary hepatic malignancies: a prospective cohort study, HPB, 2012, 14, 5
  35. 35
    Stephen L Chan, Winnie Yeo, Targeted therapy of hepatocellular carcinoma: Present and future, Journal of Gastroenterology and Hepatology, 2012, 27, 5
  36. 36
    Rahul Deshpande, Derek O'Reilly, David Sherlock, Improving Outcomes with Surgical Resection and Other Ablative Therapies in HCC, International Journal of Hepatology, 2011, 2011, 1

    CrossRef

  37. 37
    Stephen L Chan, Frankie K F Mo, Philip J Johnson, Giok S Liem, Tung C Chan, Ming C Poon, Brigette B Y Ma, Thomas W T Leung, Paul B S Lai, Anthony T C Chan, Tony S K Mok, Winnie Yeo, Prospective validation of the Chinese University Prognostic Index and comparison with other staging systems for hepatocellular carcinoma in an Asian population, Journal of Gastroenterology and Hepatology, 2011, 26, 2
  38. 38
    Binkui Li, Wenji Liu, Li Wang, Meixiang Li, Jianping Wang, Liang Huang, Pinzhu Huang, Yunfei Yuan, CpG Island Methylator Phenotype Associated with Tumor Recurrence in Tumor–Node–Metastasis Stage I Hepatocellular Carcinoma, Annals of Surgical Oncology, 2010, 17, 7, 1917

    CrossRef

  39. 39
    Beatrijs A. Seinstra, Otto M. van Delden, Karel J. van Erpecum, Richard van Hillegersberg, Willem P. Th. M. Mali, Maurice A. A. J. van den Bosch, Minimally invasive image-guided therapy for inoperable hepatocellular carcinoma: What is the evidence today?, Insights into Imaging, 2010, 1, 3, 167

    CrossRef

  40. 40
    Philip Hilgard, Monia Hamami, Amr El Fouly, André Scherag, Stefan Müller, Judith Ertle, Till Heusner, Vito R. Cicinnati, Andreas Paul, Andreas Bockisch, Guido Gerken, Gerald Antoch, Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival, Hepatology, 2010, 52, 5
  41. 41
    Mario Fernández-Ruiz, Juan Manuel Guerra-Vales, Juan Vila-Santos, Francisco Colina-Ruizdelgado, Predicción pronóstica en pacientes con carcinoma hepatocelular no subsidiario de tratamiento locorregional, Medicina Clínica, 2009, 133, 15, 581

    CrossRef

  42. 42
    Stephen L Chan, Anthony TC Chan, Winnie Yeo, Role of α-fetoprotein in hepatocellular carcinoma: prognostication, treatment monitoring or both?, Future Oncology, 2009, 5, 6, 889

    CrossRef

  43. 43
    William Sanchez, Gregory Gores, Hepatocellular Carcinoma, 2009,

    CrossRef